Earwolf

Earli is a biotechnology company pioneering the development of "Synthetic Biopsies" to detect and localize early-stage cancer. The company's platform utilizes synthetic DNA constructs that are engineered to activate only within cancer cells, forcing them to produce a synthetic biomarker that can be detected in the blood or via PET imaging. By moving beyond traditional liquid biopsies that rely on shed tumor DNA, Earli aims to identify cancer at its earliest, most curable stages. The technology is designed to not only detect the presence of cancer but also to pinpoint its exact location within the body, facilitating immediate intervention.